Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2024 Filed Mar 22, 2024 20:25 UTC |
Abel Robert LorneSee Remarks
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $27.51 | $0.00 |
DisclosureSEC source: 0001490978-24-000024 · wk-form4_1711139131.xml · derivative · entry 1 Abel Robert Lorne · CIK 0001798179 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-03-21 F1 · derivative.exercise_date: The option was granted on March 21, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 17:05 UTC |
Lorton Kenneth PatrickEVP, CTO & COO, Software
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,574 | $0.00 Strike: $4.34 | $0.00 |
DisclosureSEC source: 0001628280-24-009688 · wk-form4_1709849123.xml · derivative · entry 2 Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,574 shares Expires 2028-11-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on November 29, 2018 and is fully vested. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 17:05 UTC |
Lorton Kenneth PatrickEVP, CTO & COO, Software
|
Exercise / conversionCommon Stock | 5,574 | $4.34 | $24,191.16 |
DisclosureSEC source: 0001628280-24-009688 · wk-form4_1709849123.xml · nonDerivative · entry 1 Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,128 unvested RSUs. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 16:45 UTC |
Lorton Kenneth PatrickEVP, CTO & COO, Software
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $25.24 | $0.00 |
DisclosureSEC source: 0001628280-24-008961 · wk-form4_1709675098.xml · derivative · entry 1 Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-03-04 F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 22:13 UTC |
Porges Geoffrey CraigEVP & CFO
|
GrantStock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $25.24 | $0.00 |
DisclosureSEC source: 0001628280-24-009014 · wk-form4_1709676803.xml · derivative · entry 3 Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2034-03-04 F3 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 22:13 UTC |
Porges Geoffrey CraigEVP & CFO
|
SaleCommon Stock | 3,315 | $26.35 | $87,360.20 |
DisclosureSEC source: 0001628280-24-009014 · wk-form4_1709676803.xml · nonDerivative · entry 2 Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,685 F2 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on August 16, 2022 and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of the PRSUs on March 4, 2024. The sale does not represent a discretionary trade by the reporting person. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 22:13 UTC |
Porges Geoffrey CraigEVP & CFO
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009014 · wk-form4_1709676803.xml · nonDerivative · entry 1 Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 F1 · kind: Represents the portion of the performance-based restricted stock units ("PRSUs") that were awarded to the reporting person on August 18, 2022 in connection with the commencement of his employment that vested on March 4, 2024 following certification by the compensation committee of the issuer's board of directors of the level of achievement of certain performance metrics for the PRSUs. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:49 UTC |
Farid RamyDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 87,271 | $0.00 Strike: $27.76 | $0.00 |
DisclosureSEC source: 0001628280-24-008968 · wk-form4_1709675347.xml · derivative · entry 2 Farid Ramy · CIK 0001797707 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,271 Underlying: Common Stock · 87,271 shares Expires 2034-03-04 F2 · derivative.exercise_date: The option was granted on March 4, 2024. The exercise price per share is equal to 110% of the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:49 UTC |
Farid RamyDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 126,000 | $0.00 Strike: $25.24 | $0.00 |
DisclosureSEC source: 0001628280-24-008968 · wk-form4_1709675347.xml · derivative · entry 1 Farid Ramy · CIK 0001797707 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2034-03-04 F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:48 UTC |
Herman JennySVP & Controller
|
GrantStock Option (right to buy) · Derivative | 14,625 | $0.00 Strike: $25.24 | $0.00 |
DisclosureSEC source: 0001628280-24-008966 · wk-form4_1709675289.xml · derivative · entry 2 Herman Jenny · CIK 0001797785 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,625 Underlying: Common Stock · 14,625 shares Expires 2034-03-04 F3 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:48 UTC |
Herman JennySVP & Controller
|
GrantCommon Stock | 7,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-008966 · wk-form4_1709675289.xml · nonDerivative · entry 1 Herman Jenny · CIK 0001797785 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,074 F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 4, 2024 and will vest in equal installments on each of March 5 of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continued service with the company. F2 · balance_after: Includes 13,313 unvested RSUs. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:44 UTC |
Akinsanya KarenPresident of R&D, Therapeutics
|
GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $25.24 | $0.00 |
DisclosureSEC source: 0001628280-24-008959 · wk-form4_1709675058.xml · derivative · entry 1 Akinsanya Karen · CIK 0001797672 · President of R&D, Therapeutics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2034-03-04 F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:43 UTC |
Tran YvonneEVP, CLO & CPO
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $25.24 | $0.00 |
DisclosureSEC source: 0001628280-24-008957 · wk-form4_1709675023.xml · derivative · entry 1 Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-03-04 F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:43 UTC |
Dugan MargaretChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $25.24 | $0.00 |
DisclosureSEC source: 0001628280-24-008955 · wk-form4_1709674967.xml · derivative · entry 1 Dugan Margaret · CIK 0001909734 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-03-04 F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:39 UTC |
Abel Robert LorneSee Remarks
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $25.24 | $0.00 |
DisclosureSEC source: 0001628280-24-008948 · wk-form4_1709674728.xml · derivative · entry 1 Abel Robert Lorne · CIK 0001798179 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-03-04 F1 · derivative.exercise_date: The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028. Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 19:35 UTC |
Lorton Kenneth PatrickEVP, CTO & COO, Software
|
SaleCommon Stock | 901 | $28.29 | $25,489.29 |
DisclosureSEC source: 0001490978-24-000002 · wk-form4_1707870905.xml · nonDerivative · entry 1 Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,487 F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 9, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 6,128 unvested RSUs. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 00:39 UTC |
Tran YvonneEVP, CLO & CPO
|
SaleCommon Stock | 758 | $28.29 | $21,443.82 |
DisclosureSEC source: 0001490978-24-000008 · wk-form4_1707871134.xml · nonDerivative · entry 1 Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,963 F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 8, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 5,693 unvested RSUs. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 00:37 UTC |
Abel Robert LorneSee Remarks
|
SaleCommon Stock | 1,205 | $27.55 | $33,197.75 |
DisclosureSEC source: 0001490978-24-000006 · wk-form4_1707871058.xml · nonDerivative · entry 1 Abel Robert Lorne · CIK 0001798179 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,340 F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on June 13, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 7,909 unvested RSUs. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 00:36 UTC |
Herman JennySVP & Controller
|
SaleCommon Stock | 787 | $28.29 | $22,264.23 |
DisclosureSEC source: 0001490978-24-000004 · wk-form4_1707870979.xml · nonDerivative · entry 1 Herman Jenny · CIK 0001797785 · SVP & Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,761 F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 11, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 6,000 unvested RSUs. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 20:36 UTC |
Herman JennySVP & Controller
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,545 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001490978-23-000101 · wk-form4_1695069363.xml · derivative · entry 2 Herman Jenny · CIK 0001797785 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,545 shares Expires 2023-10-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on October 4, 2013 and is fully vested. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 20:36 UTC |
Herman JennySVP & Controller
|
Exercise / conversionCommon Stock | 4,545 | $1.20 | $5,454.00 |
DisclosureSEC source: 0001490978-23-000101 · wk-form4_1695069363.xml · nonDerivative · entry 1 Herman Jenny · CIK 0001797785 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 8,000 unvested RSUs. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 16:37 UTC |
Lorton Kenneth PatrickEVP & Chief Technology Officer
|
SaleCommon Stock | 10,000 | $40.06 | $400,642.00 |
DisclosureSEC source: 0001490978-23-000097 · wk-form4_1691699806.xml · nonDerivative · entry 1 Lorton Kenneth Patrick · CIK 0001797730 · EVP & Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,388 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnotes of this Form 4. F3 · balance_after: Includes 8,170 unvested RSUs. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 20:38 UTC |
Dugan MargaretChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $39.89 | $0.00 |
DisclosureSEC source: 0001490978-23-000099 · wk-form4_1691699891.xml · derivative · entry 2 Dugan Margaret · CIK 0001909734 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2033-08-09 F3 · derivative.exercise_date: The option was granted on August 9, 2023 under the Issuer's 2021 Inducement Equity Incentive Plan. The shares underlying the option are scheduled to vest with respect to 25% of the shares on July 31, 2024 and the remainder are scheduled to vest in equal monthly installments through July 31, 2027. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 20:38 UTC |
Dugan MargaretChief Medical Officer
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001490978-23-000099 · wk-form4_1691699891.xml · nonDerivative · entry 1 Dugan Margaret · CIK 0001909734 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Inducement Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on August 9, 2023 and will vest in equal installments on each of October 15, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continued service with the company. F2 · balance_after: Includes 15,000 unvested RSUs. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 20:16 UTC |
Tran YvonneEVP, CLO & CPO
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,040 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001490978-23-000083 · wk-form4_1688415354.xml · derivative · entry 3 Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,619 Underlying: Common Stock · 12,040 shares Expires 2030-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022. F3 · derivative.exercise_date: The option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder vest in equal monthly installments through February 5, 2024. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 20:16 UTC |
Tran YvonneEVP, CLO & CPO
|
SaleCommon Stock | 12,040 | $50.00 | $602,000.00 |
DisclosureSEC source: 0001490978-23-000083 · wk-form4_1688415354.xml · nonDerivative · entry 2 Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,721 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022. F2 · balance_after: Includes 7,590 unvested RSUs. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 20:16 UTC |
Tran YvonneEVP, CLO & CPO
|
Exercise / conversionCommon Stock | 12,040 | $17.00 | $204,680.00 |
DisclosureSEC source: 0001490978-23-000083 · wk-form4_1688415354.xml · nonDerivative · entry 1 Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022. F2 · balance_after: Includes 7,590 unvested RSUs. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 21:00 UTC |
Chodakewitz JeffreyDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $45.26 | $0.00 |
DisclosureSEC source: 0001490978-23-000080 · wk-form4_1686949225.xml · derivative · entry 2 Chodakewitz Jeffrey · CIK 0001610876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 21:00 UTC |
Chodakewitz JeffreyDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001490978-23-000080 · wk-form4_1686949225.xml · nonDerivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. F2 · ownership.direct: Includes 6,250 unvested RSUs. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 21:01 UTC |
Thornberry NancyDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $45.26 | $0.00 |
DisclosureSEC source: 0001490978-23-000081 · wk-form4_1686949266.xml · derivative · entry 2 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 21:01 UTC |
Thornberry NancyDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001490978-23-000081 · wk-form4_1686949266.xml · nonDerivative · entry 1 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. F2 · balance_after: Includes 6,250 unvested RSUs. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 21:00 UTC |
Kapeller-Libermann RosanaDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $45.26 | $0.00 |
DisclosureSEC source: 0001490978-23-000079 · wk-form4_1686949194.xml · derivative · entry 2 Kapeller-Libermann Rosana · CIK 0001797835 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 21:00 UTC |
Kapeller-Libermann RosanaDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001490978-23-000079 · wk-form4_1686949194.xml · nonDerivative · entry 1 Kapeller-Libermann Rosana · CIK 0001797835 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. F2 · balance_after: Includes 6,250 unvested RSUs. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:57 UTC |
GINSBERG GARY LDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $45.26 | $0.00 |
DisclosureSEC source: 0001490978-23-000078 · wk-form4_1686949060.xml · derivative · entry 2 GINSBERG GARY L · CIK 0001236136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:57 UTC |
GINSBERG GARY LDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001490978-23-000078 · wk-form4_1686949060.xml · nonDerivative · entry 1 GINSBERG GARY L · CIK 0001236136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. F2 · balance_after: Includes 6,250 unvested RSUs. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:56 UTC |
Friesner RichardDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $45.26 | $0.00 |
DisclosureSEC source: 0001490978-23-000077 · wk-form4_1686949008.xml · derivative · entry 4 Friesner Richard · CIK 0001798426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-06-15 F4 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:56 UTC |
Friesner RichardDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001490978-23-000077 · wk-form4_1686949008.xml · nonDerivative · entry 1 Friesner Richard · CIK 0001798426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 510,700 F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. F2 · balance_after: Includes 6,250 unvested RSUs. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:56 UTC |
Sender GaryDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $45.26 | $0.00 |
DisclosureSEC source: 0001490978-23-000076 · wk-form4_1686948952.xml · derivative · entry 2 Sender Gary · CIK 0001659085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:56 UTC |
Sender GaryDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001490978-23-000076 · wk-form4_1686948952.xml · nonDerivative · entry 1 Sender Gary · CIK 0001659085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. F2 · balance_after: Includes 6,250 unvested RSUs. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:55 UTC |
OBEROI ARUNDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $45.26 | $0.00 |
DisclosureSEC source: 0001490978-23-000075 · wk-form4_1686948913.xml · derivative · entry 2 OBEROI ARUN · CIK 0001275887 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:55 UTC |
OBEROI ARUNDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001490978-23-000075 · wk-form4_1686948913.xml · nonDerivative · entry 1 OBEROI ARUN · CIK 0001275887 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. F2 · balance_after: Includes 6,250 unvested RSUs. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:54 UTC |
Lynton MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $45.26 | $0.00 |
DisclosureSEC source: 0001490978-23-000074 · wk-form4_1686948867.xml · derivative · entry 2 Lynton Michael · CIK 0001606115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option was granted on June 15, 2023. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:54 UTC |
Lynton MichaelDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001490978-23-000074 · wk-form4_1686948867.xml · nonDerivative · entry 1 Lynton Michael · CIK 0001606115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 15, 2023 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. F2 · balance_after: Includes 6,250 unvested RSUs. Read SEC document |
| May 23, 2023 Filed May 24, 2023 17:16 UTC |
Lorton Kenneth PatrickEVP & Chief Technology Officer
|
SaleCommon Stock | 10,000 | $40.06 | $400,587.00 |
DisclosureSEC source: 0001490978-23-000057 · wk-form4_1684962973.xml · nonDerivative · entry 1 Lorton Kenneth Patrick · CIK 0001797730 · EVP & Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,388 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnotes of this Form 4. F3 · balance_after: Includes 8,170 unvested RSUs. Read SEC document |
| May 23, 2023 Filed May 24, 2023 21:19 UTC |
Tran YvonneEVP, CLO & CPO
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,960 | $4.34 Strike: $4.34 | $34,546.40 |
DisclosureSEC source: 0001490978-23-000059 · wk-form4_1684963170.xml · derivative · entry 8 Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,902 Underlying: Common Stock · 7,960 shares Expires 2028-11-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022. F6 · derivative.exercise_date: The option was granted on November 29, 2018 and is fully vested. Read SEC document |
| May 23, 2023 Filed May 24, 2023 21:19 UTC |
Tran YvonneEVP, CLO & CPO
|
SaleCommon Stock | 7,960 | $40.01 | $318,461.29 |
DisclosureSEC source: 0001490978-23-000059 · wk-form4_1684963170.xml · nonDerivative · entry 5 Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,721 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote(4) of this Form 4. F2 · balance_after: Includes 7,590 unvested RSUs Read SEC document |
| May 23, 2023 Filed May 24, 2023 21:19 UTC |
Tran YvonneEVP, CLO & CPO
|
Exercise / conversionCommon Stock | 7,960 | $4.34 | $34,546.40 |
DisclosureSEC source: 0001490978-23-000059 · wk-form4_1684963170.xml · nonDerivative · entry 4 Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022. F2 · balance_after: Includes 7,590 unvested RSUs Read SEC document |
| May 22, 2023 Filed May 23, 2023 21:05 UTC |
Thornberry NancyDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 14,850 | $0.00 Strike: $11.52 | $0.00 |
DisclosureSEC source: 0001490978-23-000050 · wk-form4_1684875940.xml · derivative · entry 3 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,020 Underlying: Common Stock · 14,850 shares Expires 2029-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022. F2 · derivative.exercise_date: The option was granted on December 2, 2019. The shares underlying the option vested with respect to 25% of the shares on December 2, 2020 and the remainder vest in equal monthly installments through December 2, 2023. Read SEC document |
| May 22, 2023 Filed May 23, 2023 21:05 UTC |
Thornberry NancyDirector
|
SaleCommon Stock | 14,850 | $35.00 | $519,750.00 |
DisclosureSEC source: 0001490978-23-000050 · wk-form4_1684875940.xml · nonDerivative · entry 2 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022. Read SEC document |
| May 22, 2023 Filed May 23, 2023 21:05 UTC |
Thornberry NancyDirector
|
Exercise / conversionCommon Stock | 14,850 | $11.52 | $171,072.00 |
DisclosureSEC source: 0001490978-23-000050 · wk-form4_1684875940.xml · nonDerivative · entry 1 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.